Neumora Therapeutics
Price & Volume
Stats
See moreOpen | $1.60 |
Previous Close | $1.63 |
Day Range | $1.58-$1.65 |
52W Range | $0.83-$3.65 |
Market Cap | $302M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.33 |
News
See moreYahoo Finance • 14 days ago
Neumora Reports Positive Toxicology Data For NMRA-215; IND Planned For Q4 '26
Yahoo Finance • 2 months ago
Weekly Buzz: SPRO, ABBV Get FDA Nod, NMRA Halts KOASTAL; ENGN Cuts Jobs; BIIB Acquires RayThera
Yahoo Finance • 2 months ago
Why Neumora Therapeutics (NMRA) Faces a Major Catalyst From Navacaprant’s Upcoming Depression Data
Yahoo Finance • 2 months ago
NMRA INVESTOR ALERT: Holzer & Holzer, LLC Investigation of Neumora Therapeutics, Inc.
About
CEO | Mr. Paul L. Berns |
CFO | Mr. Michael Lee Milligan |
Address | 260 Arsenal Place, Watertown, MA, United States, 02472 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 92 |